{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:28:33Z","timestamp":1791970113932,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.gtc.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T02:17:46Z","timestamp":1525486666000},"page":"267-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Liver Transplant for Cholangiocarcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Daniel","family":"Zamora-Valdes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.gtc.2018.01.002_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12885-016-2390-2","article-title":"Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area","volume":"16","author":"Sungkasubun","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000658-198901000-00013","article-title":"The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence","volume":"209","author":"Ringe","year":"1989","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma","volume":"239","author":"Robles","year":"2004","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.gtc.2018.01.002_bib9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/lt.20512","article-title":"Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience","volume":"11","author":"Ghali","year":"2005","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1072-7515(98)00207-5","article-title":"Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation","volume":"187","author":"Iwatsuki","year":"1998","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0002-9610(05)80696-8","article-title":"Is liver transplantation indicated for cholangiocarcinoma?","volume":"166","author":"Goldstein","year":"1993","journal-title":"Am J Surg"},{"issue":"22","key":"10.1016\/j.gtc.2018.01.002_bib12","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1002\/cncr.24572","article-title":"Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis","volume":"115","author":"Fuller","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.gtc.2018.01.002_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/1097-0142(19820401)49:7<1321::AID-CNCR2820490702>3.0.CO;2-S","article-title":"A\u00a0new method for treating carcinomatous biliary obstruction with intracatheter radium","volume":"49","author":"Conroy","year":"1982","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.gtc.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/0360-3016(84)90198-6","article-title":"Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma","volume":"10","author":"Buskirk","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000658-199202000-00006","article-title":"Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma","volume":"215","author":"Buskirk","year":"1992","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(97)00299-X","article-title":"External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma","volume":"39","author":"Foo","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archsurg.1993.01420200045008","article-title":"Outcomes after curative resections of cholangiocarcinoma","volume":"128","author":"Nagorney","year":"1993","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.surg.2006.01.010","article-title":"Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?","volume":"140","author":"Heimbach","year":"2006","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jvir.2016.12.1218","article-title":"Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: is percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? A meta-analysis","volume":"28","author":"Al Mahjoub","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"Suppl 3","key":"10.1016\/j.gtc.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"S1156","DOI":"10.1245\/s10434-015-4676-z","article-title":"Percutaneous preoperative biliary drainage for resectable perihilar cholangiocarcinoma: no association with survival and no increase in seeding metastases","volume":"22","author":"Wiggers","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.surg.2016.08.008","article-title":"Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma","volume":"161","author":"Komaya","year":"2017","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0000000000000056","article-title":"Outcome of transplant-fallout patients with unresectable cholangiocarcinoma","volume":"39","author":"Sio","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gtc.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.21107","article-title":"Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma","volume":"13","author":"Mantel","year":"2007","journal-title":"Liver Transpl"},{"issue":"S1","key":"10.1016\/j.gtc.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.hpb.2016.02.298","article-title":"Vascular complications are common following liver transplantation for hilar cholangiocarcinoma after neoadjuvant chemoradiotherapy","volume":"18","author":"Zamora-Valdes","year":"2016","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/PAS.0000000000000588","article-title":"Prognostic significance of the histologic response of perihilar cholangiocarcinoma to preoperative neoadjuvant chemoradiation in liver explants","volume":"40","author":"Lehrke","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"213","author":"Rosen","year":"1991","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gtc.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.gtc.2018.01.002_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.gtc.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000478-200303000-00008","article-title":"The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis","volume":"27","author":"Katabi","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.gtc.2018.01.002_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"Tischendorf","year":"2006","journal-title":"Endoscopy"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1055\/s-0034-1391845","article-title":"Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis","volume":"47","author":"Arnelo","year":"2015","journal-title":"Endoscopy"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2018.01.002_bib46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/apt.13817","article-title":"Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"44","author":"Njei","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.gie.2011.08.022","article-title":"Polysomy and p16 deletion by fluorescence in\u00a0situ hybridization in the diagnosis of indeterminate biliary strictures","volume":"75","author":"Gonda","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.gtc.2018.01.002_bib48","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in\u00a0situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"issue":"12 Suppl 3","key":"10.1016\/j.gtc.2018.01.002_bib49","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1002\/lt.20965","article-title":"Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia","volume":"12","author":"Gores","year":"2006","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9610(97)00203-1","article-title":"Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma","volume":"174","author":"McMasters","year":"1997","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/SLA.0000000000001384","article-title":"Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients","volume":"262","author":"Agopian","year":"2015","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib53","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg Gynecol Obstet"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib55","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0b013e31819ecc5c","article-title":"Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy","volume":"249","author":"Hwang","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jhbp.200","article-title":"Assessment of percutaneous transhepatic portal vein embolization with portal vein stenting for perihilar cholangiocarcinoma with severe portal vein stenosis","volume":"22","author":"Hyodo","year":"2015","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hpb.2016.10.008","article-title":"High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry","volume":"19","author":"Olthof","year":"2017","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib58","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/SLA.0b013e3182822277","article-title":"Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes","volume":"257","author":"Aoba","year":"2013","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/SLA.0000000000001944","article-title":"Residual carcinoma in\u00a0situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas","volume":"266","author":"Tsukahara","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2015.01.064","article-title":"Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma?","volume":"221","author":"Croome","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2018.01.002_bib62","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in Olmsted County, Minnesota, 1976-2008","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12876-016-0527-z","article-title":"Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database","volume":"16","author":"Yao","year":"2016","journal-title":"BMC Gastroenterol"},{"issue":"9085","key":"10.1016\/j.gtc.2018.01.002_bib64","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(05)63789-0","article-title":"Increase in primary liver cancer in the UK, 1979-94","volume":"350","author":"Taylor-Robinson","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib65","first-page":"232","article-title":"Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan","volume":"20","author":"Kato","year":"1990","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib66","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00330-015-4005-8","article-title":"Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging","volume":"26","author":"Kim","year":"2016","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib67","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2013.02.013","article-title":"Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis","volume":"58","author":"Iavarone","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1148\/radiol.2016151205","article-title":"Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging","volume":"281","author":"Huang","year":"2016","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib69","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.23071","article-title":"Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma","volume":"50","author":"Rimola","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1148\/radiol.2016160639","article-title":"Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT","volume":"282","author":"Choi","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.sla.0000149426.08580.a1","article-title":"Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period","volume":"241","author":"Lang","year":"2005","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib72","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1245\/s10434-012-2808-2","article-title":"Role of major vascular resection in patients with intrahepatic cholangiocarcinoma","volume":"20","author":"Ali","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gtc.2018.01.002_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.24633","article-title":"Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"116","author":"Reames","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib74","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","article-title":"A\u00a0nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience","volume":"149","author":"Hyder","year":"2014","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.gtc.2018.01.002_bib75","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/hpb.12333","article-title":"Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience","volume":"17","author":"Ali","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jso.24381","article-title":"Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: a national cohort analysis","volume":"114","author":"Bergquist","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"22","key":"10.1016\/j.gtc.2018.01.002_bib78","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.gtc.2018.01.002_bib79","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/cncr.25712","article-title":"AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group","volume":"117","author":"Farges","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib80","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/jamasurg.2015.0219","article-title":"Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients","volume":"150","author":"Spolverato","year":"2015","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.gtc.2018.01.002_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cncr.29686","article-title":"Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan","volume":"122","author":"Sakamoto","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib82","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.gtc.2018.01.002_bib83","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or\u00a0mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study","volume":"259","author":"Sapisochin","year":"2014","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib84","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"4S2","key":"10.1016\/j.gtc.2018.01.002_bib85","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.jamcollsurg.2016.08.485","article-title":"Survival after liver transplantation for intrahepatic cholangiocarcinoma: analysis of the National Cancer Data Base","volume":"223","author":"Groeschl","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.gtc.2018.01.002_bib86","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.2011.116","article-title":"Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.gtc.2018.01.002_bib87","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamcollsurg.2010.12.005","article-title":"Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma","volume":"212","author":"Hong","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"issue":"9","key":"10.1016\/j.gtc.2018.01.002_bib88","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1245\/s10434-014-4365-3","article-title":"Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment","volume":"22","author":"Rayar","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gtc.2018.01.002_bib89","doi-asserted-by":"crossref","first-page":"401","DOI":"10.15403\/jgld.2014.1121.253.y90","article-title":"Multimodal therapy including yttrium-90 radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma","volume":"25","author":"Rayar","year":"2016","journal-title":"J\u00a0Gastrointestin Liver Dis"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T16:27:54Z","timestamp":1604248074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855318300025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889855318300025"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2018.01.002","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Transplant for Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}